Results: 1-5 |
Results: 5

Authors: Speiser, DE Colonna, M Ayyoub, M Cella, M Pittet, MJ Batard, P Valmori, D Guillaume, P Lienard, D Cerottini, JC Romero, P
Citation: De. Speiser et al., The activatory receptor 2B4 is expressed in vivo by human CD8(+) effector alpha beta T cells, J IMMUNOL, 167(11), 2001, pp. 6165-6170

Authors: Blanchet, JS Valmori, D Dufau, I Ayyoub, M Nguyen, C Guillaume, P Monsarrat, B Cerottini, JC Romero, P Gairin, JE
Citation: Js. Blanchet et al., A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: Implication for molecular anti-melanoma immunotherapy, J IMMUNOL, 167(10), 2001, pp. 5852-5861

Authors: Ayyoub, M Migliaccio, M Guillaume, P Lienard, D Cerottini, JC Romero, P Levy, F Speiser, DE Valmori, D
Citation: M. Ayyoub et al., Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing., EUR J IMMUN, 31(9), 2001, pp. 2642-2651

Authors: Ayyoub, M Mazarguil, H Monsarrat, B Van den Eynde, B Gairin, JE
Citation: M. Ayyoub et al., A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells, J BIOL CHEM, 274(15), 1999, pp. 10227-10234

Authors: Ayyoub, M
Citation: M. Ayyoub, Cytotoxic T-lymphocyte responses to melanoma antigens, ANN DER VEN, 125, 1998, pp. S34-S36
Risultati: 1-5 |